Steven W. Pipe, MD, discusses real-world evidence comparing factor replacement to emicizumab in hemophilia A, exploring efficacy, adherence, and cost considerations. This is a video synopsis/summary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results